SCHEMBL7407200

SCHEMBL7407200

O=C(O)C[C@H](Cc1ccc(-c2ccccc2)cc1)NCP(=O)(Oc1ccccc1)Oc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MME P08473 10/20 0.47
MMEL1 Q495T6 6/20 0.47
PPARG P37231 2/20 0.42
PPARA Q07869 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7407913 0.88 MME (0.56) MMEMMEL1
SCHEMBL7415376 0.86 MME (0.48) MMEMMEL1
SCHEMBL7407175 0.84 MME (0.48) MMEPPARGPPARA
Hydrochloric Acid SCHEMBL7413814 0.82 MME (0.51) MMEMMEL1
Hydrochloric Acid SCHEMBL7413822 0.82 MME (0.51) MMEMMEL1
SCHEMBL7310748 0.80 MME (0.55) MMEMMEL1
SCHEMBL7310756 0.80 MME (0.55) MMEMMEL1
SCHEMBL8921950 0.79 MMEL1 (0.48) MMEMMEL1
SCHEMBL7404577 0.79 F2 (0.47) PPARGPPARA
SCHEMBL7309973 0.78 MMEL1 (0.58) MMEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660840-B1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
WO-1996026729-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES AS ECE INHIBITORS CIBA-GEIGY AG (CH) 1996-09-06 WO disclosed
US-5550119-A ENDOTHELIN-CONVERTING ENZYM INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-08-27 US disclosed
EP-0660840-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES. CIBA GEIGY AG (CH) 1995-07-05 EP disclosed
WO-1994005677-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA-GEIGY AG (CH) 1994-03-17 WO disclosed
US-5250522-A Neutral endopeptidase inhibitors; cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-10-05 US disclosed